DU
BCRX icon

Delphia (USA)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Delphia (USA)’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,584
Closed -$122K – 269
2022
Q4 		$122K Buy
+10,584
New +$122K 0.14% 231